Trending...
- Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
- Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
- myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
CANTON, Mich.--(BUSINESS WIRE)--TrialAssure® – a leading, global software company advancing clinical trial disclosure and data transparency – has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently. Leveraging the power of the cloud for processing, this software has been shown to save as much as 80 percent of the effort involved in the redaction and anonymization process for PDFs based on flexible and reusable rule setting features – as compared to traditional manual redaction.
TrialAssure ANONYMIZE for Documents is a first-in-class document redaction and anonymization software that combines machine learning – a form of artificial intelligence (AI) - and natural language processing (NLP) to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text. Through a streamlined, configurable rules-based approach, ANONYMIZE for Documents is able to quickly process documents, including:
"We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents," said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. "The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research."
More on Michimich.com
Machine learning makes document transparency easier
Through machine learning and AI, TrialAssure ANONYMIZE for Documents uses NLP to extract information whenever text is transformed, and the system then feeds this data into powerful machine learning algorithms. In doing so, ANONYMIZE for Documents improves over time in identifying where and how text should be replaced.
Before finalizing changes, users are encouraged to review all suggested anonymizations within its unique user interface. In this most recent release, users are able to review, accept, and/or reject changes within the system. The system also auto-updates the rule set applied to the document based on reviewer feedback. This leads to greater efficiencies and data traceability.
"The future of clinical trials – especially as we move to a virtual or decentralized model – is dependent on the right technology to provide secure data sharing, while ensuring that the privacy of participants and company confidential information is respected," said Mohamad Zahreddine, Chief Information Officer, TrialAssure, and member of the Forbes Technology Council. "We are on a mission to ensure that the entire industry can be transparent, allowing for increased trust and improved lives, and to do that, we must start with correctly anonymizing your documents and data."
More on Michimich.com
Pharmaceutical companies, universities, and clinical research organizations (CROs) that want to stay in front of global anonymization regulations, including European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI), can request a demo of ANONYMIZE for Documents at www.trialassure.com.
About TrialAssure
TrialAssure is a leading, global clinical trial disclosure and data transparency software suite with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and informed technology and service solutions to help clinical trial sponsors meet clinical trial registration and results reporting, document and data anonymization, patient engagement, and compliance reporting goals. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was recently named Data Solution of the Year—Healthcare in the Data Breakthrough Awards. For more information, visit: www.trialassure.com or follow TrialAssure on LinkedIn.
TrialAssure ANONYMIZE for Documents is a first-in-class document redaction and anonymization software that combines machine learning – a form of artificial intelligence (AI) - and natural language processing (NLP) to protect patient privacy by automatically finding, masking, anonymizing, or removing personal or company confidential information from unstructured text. Through a streamlined, configurable rules-based approach, ANONYMIZE for Documents is able to quickly process documents, including:
- Clinical Study Reports (CSRs) and CSR amendments
- Clinical Study Protocols
- Statistical Analysis Plans (SAPs)
- Module 2-5 documents
- Patient Narratives
- Any other document formats including Adobe PDF and Microsoft Word
"We are seeing a dramatic increase in the need for clinical trial sponsors to complete new and retrospective anonymization of clinical documents," said Kelly Vaillant, Director of Global Transparency Strategy & Compliance, TrialAssure. "The impetus for document anonymization comes as increasing regulations from global health authorities and added pressure from advocacy groups push for the expanded utility of data for secondary research."
More on Michimich.com
- Roofman USA Encourages Ann Arbor Homeowners to Plan Ahead for Roof Replacements in 2026
- Wilderness Construction Highlights Design Details That Transform Bathrooms into Spa Sanctuaries
- Japanese Martial Arts Center Helps Students Find Strength and Balance Through Structured Training
- CMR Mechanical Shares Expert Tips to Prevent Furnace Breakdowns This Winter
- Detroit Puzzle Competition Concludes Final In-Person Round for $11,239 Prize
Machine learning makes document transparency easier
Through machine learning and AI, TrialAssure ANONYMIZE for Documents uses NLP to extract information whenever text is transformed, and the system then feeds this data into powerful machine learning algorithms. In doing so, ANONYMIZE for Documents improves over time in identifying where and how text should be replaced.
Before finalizing changes, users are encouraged to review all suggested anonymizations within its unique user interface. In this most recent release, users are able to review, accept, and/or reject changes within the system. The system also auto-updates the rule set applied to the document based on reviewer feedback. This leads to greater efficiencies and data traceability.
"The future of clinical trials – especially as we move to a virtual or decentralized model – is dependent on the right technology to provide secure data sharing, while ensuring that the privacy of participants and company confidential information is respected," said Mohamad Zahreddine, Chief Information Officer, TrialAssure, and member of the Forbes Technology Council. "We are on a mission to ensure that the entire industry can be transparent, allowing for increased trust and improved lives, and to do that, we must start with correctly anonymizing your documents and data."
More on Michimich.com
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Ohana Growth Partners Expands Into Wisconsin With Its First Planet Fitness Club
Pharmaceutical companies, universities, and clinical research organizations (CROs) that want to stay in front of global anonymization regulations, including European Medicines Agency (EMA) Policy 0070 and Health Canada Public Release of Clinical Information (PRCI), can request a demo of ANONYMIZE for Documents at www.trialassure.com.
About TrialAssure
TrialAssure is a leading, global clinical trial disclosure and data transparency software suite with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and informed technology and service solutions to help clinical trial sponsors meet clinical trial registration and results reporting, document and data anonymization, patient engagement, and compliance reporting goals. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was recently named Data Solution of the Year—Healthcare in the Data Breakthrough Awards. For more information, visit: www.trialassure.com or follow TrialAssure on LinkedIn.
Filed Under: Business
0 Comments
Latest on Michimich.com
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
- London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
- myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
- Winning the C-Suite: How to Build the Executive Case for Sustained PLM Investment
- Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
- Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
- Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
- Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites
- Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
- Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
- Coalition and CCHR Call on FDA to Review Electroshock Device and Consider a Ban
- Spark Announces 2025 Design Award Winners
- NEW Luxury Single-Family Homes Coming Soon to Manalapan - Pre-Qualify Today for Priority Appointments
- Dominic Pace Returns to the NCIS Franchise With Guest Role on NCIS: Origins
- Anderson Periodontal Wellness Attends 5th Joint Congress for Ceramic Implantology
- UK Financial Ltd Completes Full Ecosystem Conversion With Three New ERC-3643 SEC-Ready Tokens As MCAT Deadline Closes Tonight
- AI Real Estate Company Quietly Building a National Powerhouse: reAlpha Tech Corp. (N A S D A Q: AIRE)
- Inkdnylon Expands National Uniform Embroidery Services
- U.S. ICE Expands Mandatory Detention Policies for Foreign Nationals